Sequential Organ Failure Assessment predicts the outcome of SCT recipients admitted to intensive care unit

Bone Marrow Transplantation

Volumn 45, Issue 4, 2010, Pages 682-688

  Gilli, K ^a   Remberger, M ^a   Hjelmqvist, H ^a   Ringden, O ^a   Mattsson, J ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Allogeneic; APACHE; Intensive care unit; SCT; SOFA; Survival

Indexed keywords

BUSULFAN; CIPROFLOXACIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; FLUCONAZOLE; METHOTREXATE; NYSTATIN; PREDNISONE; THYMOCYTE ANTIBODY;

ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ARTICLE; CHEMOTHERAPY; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HOSPITALIZATION; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MULTIPLE ORGAN FAILURE; MYELOABLATIVE CONDITIONING; OUTCOME ASSESSMENT; PANCYTOPENIA; PRIORITY JOURNAL; PROGNOSIS; RETRANSPLANTATION; SCORING SYSTEM; WHOLE BODY RADIATION;

ADOLESCENT; ADULT; AGED; APACHE; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; INFANT; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; MULTIPLE ORGAN FAILURE; PATIENT TRANSFER; SEVERITY OF ILLNESS INDEX; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TRANSPLANTATION, HOMOLOGOUS; YOUNG ADULT;

EID: 77950598665     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/bmt.2009.220     Document Type: Article

References (34)

1. Naeem N, Reed MD, Creger RJ, Youngner SJ, Lazarus HM. Transfer of the hematopoietic stem cell transplant patient to the intensive care unit: does it really matter? Bone Marrow Transplant 2006; 37: 119-133.
2. Afessa B, Tefferi A, Hoagland HC, Letendre L, Peters SG. Outcome of recipients of bone marrow transplants who require intensive-care unit support. Mayo Clin Proc 1992; 67: 117-122.
3. Diaz MA, Vicent MG, Prudencio M, Rodriguez F, Marin C, Serrano A et al. Predicting factors for admission to an intensive care unit and clinical outcome in pediatric patients receiving hematopoietic stem cell transplantation. Haematologica 2002; 87: 292-298.
4. Martin PL. To stop or not to stop: how much support should be provided to mechanically ventilated pediatric bone marrow and stem cell transplant patients? Respir Care Clin N Am 2006; 12: 403-419.
5. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. The Acute Respiratory Distress Syndrome Network. N Engl J Med 2000; 342: 1301-1308.
6. Otero RM, Nguyen HB, Huang DT, Gaieski DF, Goyal M, Gunnerson KJ et al. Early goal-directed therapy in severe sepsis and septic shock revisited: concepts, controversies, and contemporary findings. Chest 2006; 130: 1579-1595.
7. Baron F, Storb R. Allogeneic hematopoietic cell transplantation following nonmyeloablative conditioning as treatment for hematologic malignancies and inherited blood disorders. Mol Ther 2006; 13: 26-41.
8. Forslow U, Mattsson J, Ringden O, Klominek J, Remberger M. Decreasing mortality rate in early pneumonia following hematopoietic stem cell transplantation. Scand J Infect Dis 2006; 38: 970-976.
9. Hebart H, Einsele H. Specific infectious complications after stem cell transplantation. Support Care Cancer 2004; 12: 80-85. (Pubitemid 38222491)
10. Jackson SR, Tweeddale MG, Barnett MJ, Spinelli JJ, Sutherland HJ, Reece DE et al. Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors. Bone Marrow Transplant 1998; 21: 697-704.
11. Moreno R, Vincent JL, Matos R, Mendonca A, Cantraine F, Thijs L et al. The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study. Working Group on Sepsis Related Problems of the ESICM. Intensive Care Med 1999; 25: 686-696.
12. Ulvik A, Kvale R, Wentzel-Larsen T, Flaatten H. Multiple organ failure after trauma affects even long-term survival and functional status. Crit Care 2007; 11: R95.
13. Vincent JL, de Mendonca A, Cantraine F, Moreno R, Takala J, Suter PM et al. Use of the SOFA score to assess the incidence of organ dysfunction/failure in intensive care units: results of a multicenter, prospective study. Working group on 'sepsis-related problems' of the European Society of Intensive Care Medicine. Crit Care Med 1998; 26: 1793-1800.
14. Uzunel M, Remberger M, Sairafi D, Hassan Z, Mattsson J, Omazic B et al. Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning. Transplantation 2006; 82: 913-919.
15. Remberger M, Svahn BM, Mattsson J, Ringden O. Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation. Transplantation 2004; 78: 122-127.
16. Ringden O, Horowitz MM, Sondel P, Gale RP, Biggs JC, Champlin RE et al. Methotrexate, cyclosporine, or both to prevent graft-versus-host disease after HLA-identical sibling bone marrow transplants for early leukemia? Blood 1993; 81: 1094-1101.
17. Storb R, Deeg HJ, Whitehead J, Appelbaum F, Beatty P, Bensinger W et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729-735. (Pubitemid 16124386)
18. Hentschke P, Remberger M, Mattsson J, Barkholt L, Aschan J, Ljungman P et al. Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factors. Transplantation 2002; 73: 930-936.
19. Vincent JL, Moreno R, Takala J, Willatts S, De Mendonca A, Bruining H et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. On behalf of the Working Group on Sepsis-Related Problems of the European Society of Intensive Care Medicine. Intensive Care Med 1996; 22: 707-710.
20. Faber-Langendoen K, Caplan AL, McGlave PB. Survival of adult bone marrow transplant patients receiving mechanical ventilation: a case for restricted use. Bone Marrow Transplant 1993; 12: 501-507.
21. Schuster DP, Marion JM. Precedents for meaningful recovery during treatment in a medical intensive care unit. Outcome in patients with hematologic malignancy. Am J Med 1983; 75: 402-408.
22. Tremblay LN, Hyland RH, Schouten BD, Hanly PJ. Survival of acute myelogenous leukemia patients requiring intubation/ ventilatory support. Clin Invest Med 1995; 18: 19-24.
23. Kew AK, Couban S, Patrick W, Thompson K, White D. Outcome of hematopoietic stem cell transplant recipients admitted to the intensive care unit. Biol Blood Marrow Transplant 2006; 12: 301-305.
24. Lim Z, Pagliuca A, Simpson S, Cottam S, Ervine M, Ho AY et al. Outcomes of patients with haematological malignancies admitted to intensive care unit. A comparative review of allogeneic haematopoietic stem cell transplantation data. Br J Haematol 2007; 136: 448-450.
25. Ringden O, Le Blanc K. Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives. APMIS 2005; 113: 813-830. (Pubitemid 43934223)
26. Ringden O, Remberger M, Ruutu T, Nikoskelainen J, Volin L, Vindelov L et al. Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group. Blood 1999; 93: 2196-2201.
27. Inoue T, Ikeda H, Yamazaki H, Tang JT, Song C, Teshima T et al. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission. Strahlenther Onkol 1993; 169: 250-255.
28. Morgan M, Dodds A, Atkinson K, Szer J, Downs K, Biggs J. The toxicity of busulphan and cyclophosphamide as the preparative regimen for bone marrow transplantation. Br J Haematol 1991; 77: 529-534.
29. Trinkaus MA, Lapinsky SE, Crump M, Keating A, Reece DE, Chen C et al. Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit. Bone Marrow Transplant 2009; 43: 411-415.
30. Michallet M, Tanguy ML, Socie G, Thiebaut A, Belhabri A, Milpied N et al. Second allogeneic haematopoietic stem cell transplantation in relapsed acute and chronic leukaemias for patients who underwent a first allogeneic bone marrow transplantation: a survey of the Societe Francaise de Greffe de moelle (SFGM). Br J Haematol 2000; 108: 400-407.
31. Larsson K, Gamrin L, Wernerman J. Mortalitet under IVA-vard. In: SFAI-Veckan: Norrkoping, 2005.
32. Silfvast T, Pettila V, Ihalainen A, Elonen E. Multiple organ failure and outcome of critically ill patients with haematological malignancy. Acta Anaesthesiol Scand 2003; 47: 301-306.
33. Jones AE, Focht A, Horton JM, Kline JA. Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock. Chest 2007; 132: 425-432.
34. Rivers E. The outcome of patients presenting to the emergency department with severe sepsis or septic shock. Crit Care 2006; 10: 154.